Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    

Vanderbilt University Medical Center Aids National Effort to "Repurpose" Drugs for COVID-19

Chris Lindsell, PhD

Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at "repurposing" existing drugs to treat mild to moderate symptoms of COVID-19.

The Duke Clinical Research Institute (DCRI) is the Clinical Coordinating Center for the ACTIV-6 platform announced today<April 19> by the National Institutes of Health (NIH). DCRI has contracted with VUMC for data coordinating services. NIH will provide an initial investment of $155 million in funding for the trial.

The DCC principal investigator is Chris Lindsell, PhD, professor of Biostatistics and director of the Research Methods Program in the Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at VUMC.

Currently there are no therapies approved specifically to treat mild to moderate COVID-19 symptoms. The goal of ACTIV-6, part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, is to prioritize and speed development of the most promising treatments.

"We have designed the ACTIV-6 platform to make it easy for anyone to take part, no matter where they live," Lindsell said. "Because we are repurposing existing drugs, it is increasingly possible to deliver research therapies directly to someone's home.

"Combining easy access to the study with advanced ways of analyzing the data, we will quickly sort through already available, safe drugs to find which ones might help people feel better sooner while also keeping them out of the hospital," he said.

The National Center for Advancing Translational Sciences (NCATS), part of the NIH, is sponsoring the ACTIV-6 platform with funding from theBiomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services.

PCORnet, the National Patient-Centered Clinical Research Network, will support ACTIV-6 governance and operations, and PCORnet sites including VUMC will enroll participants from a broad range of communities. PCORnet funding comes from the Patient-Centered Outcomes Research Institute (PCORI), an independent non-profit research organization.


Related Articles:

Recent Articles

AACR Establishes New Cancer Evolution Working Group

The American Association for Cancer Research (AACR) announced the formation of its seventh and newest scientific working group, which will be dedicated to supporting cancer evolution research.

Read More

Global Dementia Cases Forecasted To Triple By 2050

New analysis shows a decrease in prevalence due to education countered by increase due to heart health risk factors

Read More

Blackburn, Feinstein Introduce Bill to Protect Access to Breast Cancer Screenings

U.S. Senators Marsha Blackburn (R-Tenn.) and Dianne Feinstein (D-Calif.) today introduced the Protecting Access to Lifesaving Screenings (PALS) Act of 2021, a bill to preserve coverage for routine breast cancer screening for women beginning at age 40.

Read More


The company's 2020 sustainability report highlights its commitment to environmental, social and governance (ESG) activities

Read More

Mobile Mentor Named Winner of Microsoft's 2021 Partner of the Year for Modern Endpoint Management

Mobile Mentor announced they have been awarded the 2021 Global Partner of the Year Award for Modern Endpoint Management.

Read More

Alzheimer's Association Welcomes CMS Announcement of National Coverage Determination Analysis on Treatment for Alzheimer's Disease

On behalf of all those living with Alzheimer's disease, their caregivers, and their families, we appreciate the Centers for Medicare & Medicaid Services (CMS) thoughtful consideration on coverage considerations for monoclonal antibodies targeting amyloid for the treatment of Alzheimer's disease, including aducanumab, which was recently approved by the Food and Drug Administration (FDA).

Read More

HCTec Acquires Talon Healthy IT Services

Healthcare IT firm adds industry-leading help desk service company to portfolio of solutions

Read More

The Seven Steps of Revenue Cycle for a Healthcare Practice

Revenue cycle management tracks patient revenue from the initial encounter with the healthcare system to payment of balance. Getting the seven steps of revenue cycle right helps providers avoid missteps that are costly to the bottom line.

Read More

Expanding Evidence-Based Care for Dementia

The Alzheimer's Association is on a mission to ensure care professionals have access to evidence-based training to ensure those with dementia receive quality care across all settings.

Read More

A Natural Leader

Nashville physician Dr. Ryan Mire to head nation's largest medical-specialty society.

Read More

Email Print



Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: